Product Recalls in Ohio

Product recalls affecting Ohio — including food, drugs, consumer products, medical devices, and vehicles distributed to Ohio. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,807 recalls have been distributed to Ohio in the last 12 months.

55,415 total recalls
2,807 in last 12 months

Showing 701720 of 13,469 recalls

DrugFebruary 13, 2025· Johnson, S C and Son, Inc

Recalled Item: Kids by babyganics SPF 50 mineral sunscreen totally tropical (titanium...

The Issue: Chemical Contamination

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 13, 2025· ICU Medical, Inc.

Recalled Item: POTASSIUM CHLORIDE Inj. Recalled by ICU Medical, Inc. Due to Labeling: Label...

The Issue: Labeling: Label Error on Declared Strength. Overwrap labeled as Potassium...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugFebruary 13, 2025· ICU Medical, Inc.

Recalled Item: POTASSIUM CHLORIDE Inj. Recalled by ICU Medical, Inc. Due to Mislabeling

The Issue: Labeling: Label Error on Declared Strength. Cases labeled POTASSIUM CHLORIDE...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugFebruary 13, 2025· Johnson, S C and Son, Inc

Recalled Item: Kids by babyganics SPF 50 totally tropical (titanium dioxide 3/5% Recalled...

The Issue: Chemical Contamination

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 13, 2025· Zydus Pharmaceuticals (USA) Inc

Recalled Item: Nelarabine Injection Recalled by Zydus Pharmaceuticals (USA) Inc Due to...

The Issue: Failed Impurities/Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 13, 2025· Zydus Pharmaceuticals (USA) Inc

Recalled Item: Nelarabine Injection Recalled by Zydus Pharmaceuticals (USA) Inc Due to...

The Issue: Failed Impurities/Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 10, 2025· Nephron Sterile Compounding Center LLC

Recalled Item: Sodium Chloride Injection 9% Recalled by Nephron Sterile Compounding Center...

The Issue: Lack of Assurance of Sterility: There is a potential for leakage at the IV...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 6, 2025· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Morphine Sulfate Extended-Release Tablets Recalled by SUN PHARMACEUTICAL...

The Issue: Failed Dissolution Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 6, 2025· Padagis US LLC

Recalled Item: Estradiol Gel Recalled by Padagis US LLC Due to Defective Container: Some...

The Issue: Defective Container: Some packets may not be fully sealed, potentially...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 4, 2025· AvKARE

Recalled Item: Silodosin Capsules Recalled by AvKARE Due to Subpotent Drug: Out of...

The Issue: Subpotent Drug: Out of Specification (OOS) result for De hydro Impurity...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 31, 2025· Alvogen, Inc

Recalled Item: Fentanyl Transdermal System CII Recalled by Alvogen, Inc Due to Defective...

The Issue: Defective delivery system - patches could be multi-stacked, adhered one on...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugJanuary 30, 2025· The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Recalled Item: Potassium Chloride Extended-Release Tablets Recalled by The Harvard Drug...

The Issue: Failed Dissolution Specifications.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund